These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 11031971

  • 1. [Paraneoplastic Crow-Fukase syndrome].
    Arai K.
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):367-9. PubMed ID: 11031971
    [No Abstract] [Full Text] [Related]

  • 2. [Crow-Fukase (POEMS) syndrome].
    Hashiguchi T, Arimura K, Osame M.
    Ryoikibetsu Shokogun Shirizu; 2000; (32):595-8. PubMed ID: 11212815
    [No Abstract] [Full Text] [Related]

  • 3. [Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome].
    Arimura K.
    Rinsho Shinkeigaku; 1999 Jan; 39(1):84-5. PubMed ID: 10377815
    [Abstract] [Full Text] [Related]

  • 4. [Crow-Fukase syndrome].
    Hitoshi S, Kusunoki S.
    Ryoikibetsu Shokogun Shirizu; 1999 Jan; (27 Pt 2):496-9. PubMed ID: 10434708
    [No Abstract] [Full Text] [Related]

  • 5. [Contribution of Japanese researchers to progress in the field of neurology in the last 100 years: Crow-Fukase (POEMS)].
    Nishitani H.
    Nihon Naika Gakkai Zasshi; 2002 Aug 10; 91(8):2316-20. PubMed ID: 12373841
    [No Abstract] [Full Text] [Related]

  • 6. [Vascular endothelial growth factor and Crow-Fukase syndrome].
    Arimura K, Osame M, Hashiguchi T.
    Rinsho Shinkeigaku; 2001 Dec 10; 41(12):1144-6. PubMed ID: 12235821
    [Abstract] [Full Text] [Related]

  • 7. [Peripheral neuropathy in the POEMS syndrome].
    Fernández-Torre JL.
    Neurologia; 2001 Dec 10; 16(7):331-3. PubMed ID: 11485728
    [No Abstract] [Full Text] [Related]

  • 8. [POEMS syndrome (Crow-Fukase syndrome)].
    Hirata M.
    Nihon Rinsho; 2006 Sep 28; Suppl 3():601-4. PubMed ID: 17022618
    [No Abstract] [Full Text] [Related]

  • 9. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.
    Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, Matsuo K, Arisato T, Osame M.
    Muscle Nerve; 1998 Nov 28; 21(11):1390-7. PubMed ID: 9771661
    [Abstract] [Full Text] [Related]

  • 10. VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome.
    Niimi H, Arimura K, Jonosono M, Hashiguchi T, Kawabata M, Osame M, Kitajima I.
    Intern Med; 2000 Dec 28; 39(12):1101-4. PubMed ID: 11197800
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of vascular endothelial growth factor and its receptor, Flt-1, in glomeruloid haemangioma associated with Crow-Fukase syndrome.
    Yamamoto T, Yokozeki H.
    J Eur Acad Dermatol Venereol; 2007 Mar 28; 21(3):417-9. PubMed ID: 17309484
    [No Abstract] [Full Text] [Related]

  • 12. Increased serum level of vascular endothelial growth factor in Crow-Fukase syndrome.
    Yamamoto T, Kuroda M, Nishioka K.
    Acta Derm Venereol; 2001 Mar 28; 81(4):317-8. PubMed ID: 11720194
    [No Abstract] [Full Text] [Related]

  • 13. [A case of Crow-Fukase syndrome with extramedullary plasmacytoma: marked clinical deterioration following a biopsy to plasmacytoma].
    Takakura Y, Yamaguchi Y, Miyoshi T.
    Rinsho Shinkeigaku; 2003 Apr 28; 43(4):170-5. PubMed ID: 12884826
    [Abstract] [Full Text] [Related]

  • 14. [A case of anaphylactoid shock occurring immediately after the initiation of second intravenous administration of high-dose immunoglobulin (IVIg) in a patient with Crow-Fukase syndrome].
    Takahashi T, Ono S, Ogawa K, Tamura M, Mizutani T.
    Rinsho Shinkeigaku; 2003 Jun 28; 43(6):350-5. PubMed ID: 14503355
    [Abstract] [Full Text] [Related]

  • 15. [Crow-Fukase syndrome and VEGF].
    Arimura K, Hashiguchi T, Watanabe O.
    Brain Nerve; 2008 Jun 28; 60(6):611-9. PubMed ID: 18567356
    [Abstract] [Full Text] [Related]

  • 16. [Vascular endothelial growth factor receptor--structure and function].
    Liu L, Hu BC, Zhang YJ.
    Sheng Li Ke Xue Jin Zhan; 2000 Jul 28; 31(3):269-72. PubMed ID: 12545721
    [No Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor and coronary artery surgery: implications for improved endothelial protection!
    Chambers DJ.
    Eur Heart J; 2000 Oct 28; 21(20):1649-51. PubMed ID: 11032690
    [No Abstract] [Full Text] [Related]

  • 18. Crow-Fukase syndrome associated with high-output heart failure.
    Araki T, Konno T, Soma R, Nakashima A, Takimoto H, Tofuku Y, Shimizu M.
    Intern Med; 2002 Aug 28; 41(8):638-41. PubMed ID: 12211533
    [Abstract] [Full Text] [Related]

  • 19. [Vascular endothelial growth factor. Its role in peritoneal physiopathology].
    Selgas R, del Peso G, Bajo MA, Cirugeda A, Sánchez-Tomero JA, Alvarez V.
    Nefrologia; 2001 Aug 28; 21(5):423-5. PubMed ID: 11795005
    [No Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS.
    J Clin Oncol; 2000 Nov 01; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.